MCT8 deficiency is a rare genetic condition that mostly affects boys. It happens when a gene called SLC16A2 does not work properly. This gene makes a “carrier” protein called MCT8 that normally moves thyroid? hormones (especially T3 and T4) into brain cells. When MCT8 does not work, the brain does not get enough thyroid hormone during pregnancy and early life. The brain then develops more slowly. At the same time, too much active thyroid hormone (T3) stays in the blood and other body tissues, which can make the body act as if it has too much thyroid hormone. This is why children with MCT8 deficiency can have both brain-related problems (due to too little thyroid? hormone in the brain) and body-related signs (due to too much thyroid? hormone in the rest of the body). The condition is X-linked, so it mainly affects males; females can be healthy carriers, although a few may have mild features. NCBI+2PMC+2

A typical thyroid? blood test pattern in MCT8 deficiency is high T3, low T4, low reverse T3 (rT3), and normal or slightly low TSH. Doctors often think of MCT8 deficiency when they see this pattern in a baby boy with weak muscle tone and slow development. PMC

Brain MRI often shows delayed myelination (the “insulation” of brain wiring develops late), although in some children this delay can be partial or even improve over time. PMC+2PubMed+2

Other names

• Allan-Herndon-Dudley syndrome (AHDS)

• MCT8-specific thyroid? hormone transporter deficiency

• SLC16A2-related disorder
  All of these refer to the same condition. Genetic Diseases Information Center+1

Types

There is one underlying disease (caused by SLC16A2 variants), but doctors sometimes describe types by how severe the features are and when they show up:

1. Classic early-onset type – symptoms appear in infancy: poor head control, low muscle tone, feeding difficulty, and later spasticity with severe developmental delay. Thyroid? tests show the typical pattern (high T3, low T4). NCBI+1

2. Moderate/variable type – similar features but slightly milder movement problems or partial speech/communication; severity can vary depending on the exact gene change. PMC

3. Female carrier spectrum – most female carriers are healthy; a small number can have mild learning or movement problems due to X-inactivation patterns. NCBI

4. Neuro-imaging subtypes – many children have delayed myelination on MRI; a few may show near-normal myelination later. PMC+1

Causes

MCT8 deficiency is genetic. “Causes” here means the different ways the SLC16A2 gene or the MCT8 protein can be disrupted, plus factors that determine how strongly the disorder shows itself.

1. Missense variants in SLC16A2 that change one amino acid and make the transporter move thyroid? hormone poorly. PMC

2. Nonsense variants that create a premature stop signal and truncate the MCT8 protein. PMC

3. Frameshift variants that shift the reading frame and produce a non-functional transporter. PMC

4. Splice-site variants that prevent proper assembly of the gene’s message, lowering or ruining MCT8 production. PMC

5. Large deletions/duplications in SLC16A2 that remove or duplicate key exons or the whole gene. PMC

6. Promoter/regulatory variants that reduce how much MCT8 is made on cell membranes. PMC

7. Variants in transmembrane domains that block the T3/T4 “channel” within MCT8. PMC

8. Misfolding with ER retention – the protein is made but never reaches the cell surface to transport hormone. PMC

9. Defective membrane targeting/trafficking so MCT8 does not sit correctly in the cell membrane. PMC

10. Loss of T3 transport specifically (even if T4 transport is partly preserved), which starves brain cells of active hormone. PMC

11. Cerebral thyroid? gland makes too little hormone. সহজ বাংলা: থাইরয়েড হরমোন কম।" data-rx-term="hypothyroidism" data-rx-definition="Hypothyroidism means the thyroid gland makes too little hormone. সহজ বাংলা: থাইরয়েড হরমোন কম।">hypothyroidism? as a direct result of poor hormone entry into brain cells, impairing brain development. Frontiers

12. Peripheral thyrotoxicosis from excess circulating T3 acting on body tissues (muscle, liver, bone). Frontiers

13. X-linked inheritance (affected boys inherit the variant from a carrier mother in many families). NCBI

14. De novo variants (a new change arises for the first time in the child). NCBI

15. Skewed X-inactivation in females producing rare symptomatic females. NCBI

16. Secondary hormonal changes (high T3, low T4, low rT3) that themselves drive symptoms in the body. PMC

17. Downstream tissue effects (e.g., on muscle, liver, and bone) from long-term high T3 exposure. PMC

18. Delayed myelination disrupting fast brain signaling and motor control. PMC

19. Nutritional/feeding difficulties as a consequence (not a root genetic cause) that can worsen growth and strength. NCBI

20. Diagnostic delay (again not genetic) that prolongs exposure to abnormal thyroid? levels and missed early supports. e-apem.org

Common symptoms and signs

1. Low muscle tone in infancy (floppy baby) – the baby feels soft and cannot hold the head up well because brain-to-muscle signals are weak. NCBI

2. Feeding problems – slow suck and swallow, choking, or reflux, due to poor coordination of mouth and throat muscles. NCBI

3. Severe delay in milestones – late or absent rolling, sitting, standing, or walking because the nervous system develops slowly. NCBI

4. Intellectual disability – learning and communication are limited; many children have very few spoken words. Frontiers

5. Spasticity – stiff muscles and tight reflexes that develop after the early floppy phase, causing scissoring legs or bent arms. Frontiers

6. Dystonia/athetoid movements – twisting or writhing motions and poor control of hands and arms. Frontiers

7. Poor head control and trunk stability – difficulty keeping the head upright or sitting without support. NCBI

8. Contractures and scoliosis – joints can stiffen, and the spine can curve due to long-term muscle imbalance. Frontiers

9. Underweight or slow growth – from feeding difficulty and high energy use; some tissues behave as if “over-thyroid?.” Frontiers

10. Fast heartbeat or warm, sweaty skin – body tissues feel the effect of high T3 in blood (outside the brain). Frontiers

11. Irritability or sleep problems – common in many neurodevelopmental disorders, may be worsened by hormone imbalance. Genetic Diseases Information Center

12. Constipation? or other GI issues – mixed tone and movement issues can affect digestion. Genetic Diseases Information Center

13. Low muscle bulk – muscles may look thin from both nerve-signal problems and peripheral hormone effects. Frontiers

14. Seizures (in some) – not universal, but can occur and need evaluation. Frontiers

15. Delayed myelination on MRI (a “silent” sign) – explains slow information flow in the brain and motor control issues. PMC

Diagnostic tests

A) Physical examination (at the bedside)

1. General growth and nutrition check – measures weight, length/height, and head size; helps identify under-nutrition and guides feeding plans. NCBI

2. Tone and posture exam – documents early hypotonia and later spasticity; important for therapy planning. Frontiers

3. Cranial nerve and swallow assessment – screens suck, swallow, cough, and airway protection to prevent aspiration. NCBI

4. Movement assessment – notes dystonia/athetoid movements and involuntary motions; helps track change over time. Frontiers

5. Spine and joint exam – checks for scoliosis and contractures that may need braces, therapy, or surgery. Frontiers

B) Manual/functional tests (simple, clinic-based measures)

6. Pull-to-sit (head-lag) test – gentle traction from lying to sitting; persistent head-lag shows hypotonia and poor trunk control. NCBI

7. Range-of-motion testing – measures joint flexibility; limited range suggests contractures needing stretching/splints. Frontiers

8. Gross motor function scales (e.g., GMFM) – structured scoring of rolling, sitting, and transfers for therapy goals. NCBI

9. Feeding/swallowing evaluation at bedside – therapist watches sucking, chewing, and swallowing to plan safe feeding. NCBI

10. Developmental screening? tools (e.g., Bayley items) – quick checklists to track cognitive, language, and motor progress. NCBI

C) Laboratory and pathological tests

11. Thyroid? panel (FT3, FT4, rT3, TSH) – classic pattern is high T3, low T4, low rT3, and normal/low TSH; this pattern should prompt genetic testing for MCT8 deficiency. PMC

12. Sex hormone–binding globulin (SHBG) – often high due to T3 effect on the liver; supports the picture of peripheral thyrotoxicosis. PMC

13. Liver enzymes and metabolic panel – screens for secondary effects of excess T3 on liver and metabolism. PMC

14. Lipid profile – can shift with thyroid? hormone excess; helps monitor systemic? effects. PMC

15. Targeted SLC16A2 sequencing – confirms the diagnosis? by finding the disease-causing variant. NCBI

16. Copy-number analysis (e.g., MLPA or exome CNV) – detects exon/gene deletions or duplications when sequencing is normal. PMC

17. Carrier testing for mothers/female relatives – identifies carriers for family planning and prenatal options. NCBI

18. Prenatal testing (CVS/amniocentesis) when familial variant known – allows diagnosis? in pregnancy if desired by the family. NCBI

D) Electrodiagnostic tests

19. EEG – checks for seizures or abnormal brain electrical activity in children with spells or regression. Frontiers

20. EMG/nerve conduction or evoked potentials (selected cases) – helps separate muscle/nerve disease from central motor problems when the picture is unclear. Frontiers

E) Imaging tests

(Performed alongside labs and genetics; listed here for clarity.)

1. Brain MRI – often shows delayed myelination of white matter; this supports the diagnosis? and helps exclude other causes of motor delay. In a few children, myelination may improve or look close to normal later. PMC+2PubMed+2

Non-pharmacological treatments (therapies and others)

Each item lists description – purpose – mechanism.

1. Early developmental intervention – Frequent, family-centered therapy from infancy – Builds skills during the most plastic period – Repetition and enriched stimulation help wire motor and communication pathways.

2. Physiotherapy (neuro-developmental approach) – Daily positioning, stretching, supported sitting/standing – Prevents contractures and improves head/trunk control – Regular range-of-motion and weight-bearing promote muscle length and bone density.

3. Occupational therapy – Hand function, seating, activities of daily living – Improves comfort, feeding, and caregiving – Task-specific practice and adaptive equipment reduce effort.

4. Speech and language therapy – Oral-motor, safe swallow, and communication training – Lowers aspiration risk; builds language – Strengthens coordinated swallow and introduces cues for communication.

5. Augmentative and alternative communication (AAC) – Eye-gaze boards, switches, or speech-generating devices – Gives a reliable voice – Bypasses impaired speech using visual or switch inputs.

6. Feeding therapy & nutrition plan – Texture modifications; calorie-dense meals – Improves weight gain and reduces choking – Aligns diet with swallow safety and energy needs.

7. Reflux management without drugs – Upright positioning, small frequent feeds – Reduces vomiting?/aspiration – Gravity and pacing decrease reflux.

8. Respiratory physiotherapy – Airway clearance, cough assist as needed – Prevents pneumonia – Mobilizes secretions and supports weak cough.

9. Orthoses and seating systems – AFOs, custom seating, standing frames – Prevents deformity; supports function – External alignment counters spastic pull and improves pressure distribution.

10. 24-hour posture care – Night splints, side-lying positioning – Protects joints/skin – Maintains neutral positions during sleep.

11. Hip surveillance program – Scheduled exams and X-rays – Prevents late hip dislocation – Early detection triggers bracing/Botox/surgery at the right time.

12. Scoliosis monitoring – Regular spine checks – Maintains sitting tolerance and breathing – Early bracing or planning for surgery.

13. Bone health measures – Weight-bearing, sunlight, adequate calcium/vitamin D – Prevents fractures – Mechanical loading plus nutrients increase bone strength.

14. Behavioral sleep strategies – Consistent routines, light management – Better sleep for child and family – Stabilizes circadian cues.

15. Infection? prevention – Vaccinations, hand hygiene, airway care – Fewer respiratory setbacks – Reduces triggers for regression.

16. Caregiver training – Safe transfers, feeding, suctioning – Lowers injury risk and hospital visits – Skills and checklists improve home safety.

17. Social support and respite – Counseling, parent groups – Reduces caregiver burnout – Emotional and practical support improves adherence.

18. School-based special education – Individualized education plan – Access to learning and therapies – Structured supports meet cognitive and motor needs.

19. Transition planning (adolescence to adulthood) – Equipment, guardianship, benefits – Smooth hand-off to adult care – Early planning prevents gaps.

20. Palliative/complex care consultation (when needed) – Symptom control and goal setting – Maximizes quality of life – Team coordinates comfort-focused care. NCBI+1

Drug treatments

Important: Only some medicines target the thyroid? imbalance. Most are supportive (manage spasticity, reflux, seizures, etc.). Always treat under a specialist (pediatric neurologist + pediatric endocrinologist).

1. Triac (tiratricol; 3,3′,5-triiodothyroacetic acid) – Class: thyroid?-hormone analog – Dose: individualized; clinical trials used weight-based dosing, titrated to normalize T3 and improve signs – Timing: daily – Purpose: reduce harmful high T3 in the body and bring thyroid? action to the brain – Mechanism: enters cells and the brain better than T3 in MCT8 deficiency; lowers serum T3 and improves peripheral hyperthyroid effects; early use may improve neurodevelopment – Side effects: generally well tolerated in trials; monitor heart, growth, labs. The Lancet+2PMC+2

2. DITPA (diiodothyropropionic acid; investigational) – Class: TH analog – Dose/Timing: study-based; specialist use/clinical trial – Purpose: attempt to provide thyroid? action without worsening brain hypothyroidism? – Mechanism: partial T3-like effects that can lower T3 and TSH – Notes: promising biochemical effects in small cohorts; long-term neurodevelopmental benefit unproven; currently under further study – Side effects: monitor heart/liver/thyroid? labs. PMC+2PubMed+2

3. Sobetirome (GC-1) and Sob-AM2 (investigational, preclinical/early translational) – Class: CNS-targeted thyromimetics – Purpose: deliver T3-like action to the brain while lowering peripheral hormones – Mechanism: cross the blood–brain barrier in Mct8-deficient mice and activate T3-responsive genes; maternal dosing strategies are being studied – Status: not standard care; research setting only – Safety: unknown in children; animal data only. Liebert Publishing+2PMC+2

4. Propranolol (or other beta-blockers) – Class: beta-adrenergic blocker – Purpose: control tachycardia, tremor, sweating linked to high T3 – Mechanism: blocks beta-receptors – Side effects: bradycardia, hypotension; avoid in asthma; dose by cardiologist. NCBI

5. Clonidine / guanfacine – Class: alpha-2 agonists – Purpose: help autonomic symptoms, sleep, irritability – Mechanism: reduces sympathetic outflow – Side effects: sedation, low BP. (Supportive practice.)

6. Baclofen – Class: antispasticity – Purpose: reduce spasticity, ease care – Mechanism: GABA-B agonist – Side effects: sedation, weakness; titrate slowly.

7. Tizanidine – Class: antispasticity – Purpose: as above – Mechanism: alpha-2 agonist at spinal level – Side effects: sleepiness, liver enzyme rise; monitoring needed.

8. Diazepam (night dosing) – Class: benzodiazepine – Purpose: nocturnal spasms – Mechanism: GABA-A action – Side effects: sedation, dependence; specialist guidance.

9. Botulinum toxin injections – Class: neuromuscular blocker (local) – Purpose: focal spasticity/hip adductors – Mechanism: blocks acetylcholine release – Side effects: local weakness; repeat every 3–6 months.

10. Levetiracetam – Class: anti-seizure – Purpose: seizures if present – Mechanism: SV2A binding – Side effects: mood change; monitor.

11. Valproate – Class: anti-seizure – Purpose: broad-spectrum control – Mechanism: increases GABA; multiple actions – Side effects: liver/pancreas toxicity, weight change; avoid in mitochondrial disease.

12. Lansoprazole/omeprazole – Class: PPI – Purpose: reflux control if conservative measures fail – Mechanism: reduces gastric acid – Side effects: long-term bone/microbiome considerations; use lowest effective dose.

13. Baclofen (intrathecal pump) – Class: antispasticity (device-assisted) – Purpose: severe spasticity not controlled orally – Mechanism: spinal delivery – Side effects: pump risks; specialist centers only.

14. Glycopyrrolate – Class: anticholinergic – Purpose: drooling/aspiration risk – Mechanism: reduces salivary flow – Side effects: constipation, urine retention.

15. Melatonin – Class: sleep aid – Purpose: sleep consolidation – Mechanism: circadian cue – Side effects: usually mild; dose by weight.

16. Vitamin D and calcium – Class: supplements – Purpose: bone health – Mechanism: supports mineralization – Side effects: hypercalcemia if excessive; monitor.

17. Bisphosphonates (selected cases) – Class: anti-resorptives – Purpose: treat low bone density with fractures – Mechanism: inhibit osteoclasts – Side effects: infusion reactions; dental planning needed.

18. Antibiotics per guideline – Class: anti-infective – Purpose: treat pneumonia/UTIs promptly – Mechanism: pathogen-specific – Side effects: drug-specific; stewardship important.

19. Thyroid hormone replacement (levothyroxine/T3) – generally not effective/appropriate as sole therapy – Reason: may worsen peripheral thyrotoxicosis and does not fix brain entry – Use only under expert protocols. NCBI

20. Triac access via clinical programs – Note: In regions where Triac is approved or accessible (e.g., named-patient/clinical trial), endocrinology teams follow trial-based titration and safety labs; early initiation appears most promising. The Lancet+1

Dietary / molecular supplements

Always discuss supplements with your care team to avoid interactions and excess iodine.

1. Energy-dense feeds (modular powders/oils) – Dose: dietitian-directed – Function: improve calories – Mechanism: closes energy gap from high T3 catabolism. NCBI

2. Vitamin D – Dose: per labs/age – Function: bone health – Mechanism: calcium absorption.

3. Calcium – Dose: age-based total intake – Function: bone mineralization – Mechanism: substrate for bone.

4. Protein fortification – Dose: g/kg/day targets – Function: growth and muscle – Mechanism: supports anabolism.

5. Iron (if deficient) – Dose: mg/kg/day per labs – Function: anemia, sleep – Mechanism: hemoglobin and neurotransmitter synthesis.

6. Fiber and fluids – Dose: dietitian plan – Function: constipation control – Mechanism: stool bulk and motility.

7. Omega-3 (DHA/EPA) – Dose: age-appropriate – Function: general neuro-nutritional support – Mechanism: membrane fluidity; anti-inflammatory.

8. Selenium (only if deficient; avoid excess) – Function: thyroid enzyme support – Mechanism: selenoproteins – Note: unnecessary supplementation can be harmful.

9. Multivitamin without iodine (if advised) – Function: fills gaps – Mechanism: baseline micronutrients while avoiding iodine load that can affect thyroid balance.

10. Thickening agents for liquids – Function: safer swallow – Mechanism: slows flow to reduce aspiration.

(There is no proven supplement that cures MCT8 deficiency; these measures support nutrition, bones, and safety.) NCBI

Immunity-booster / regenerative / stem-cell” drugs

There are no approved immune-booster or stem-cell drugs that treat MCT8 deficiency. The focus is on thyroid-hormone analogs and brain delivery strategies. Below are research-oriented or conceptual approaches; these are not standard care:

1. Triac (tiratricol) – disease-modifying candidate; improves thyroid balance; not an immune or stem-cell therapy. The Lancet

2. DITPA – investigational thyromimetic; biochemical benefits reported; long-term neurodevelopmental gains unclear. PMC+1

3. Sobetirome / Sob-AM2 – CNS-targeted thyromimetics in animals; possible future maternal-fetal or pediatric application; research only. PMC

4. AAV-based gene therapy (concept) – deliver a working SLC16A2 to brain cells; at preclinical/early translational stage; not in routine clinical use. Bioscientifica

5. Nanoparticle/lipophilic pro-drug T3 delivery (concept) – bypass MCT8 by changing drug chemistry; early research. Bioscientifica

6. Combination strategies (thyromimetic + peripheral T3 lowering) – aim to treat brain while protecting body; being explored scientifically. Bioscientifica

Bottom line: avoid unproven “immune boosters” or stem-cell products marketed online. Discuss clinical trials with your specialist team. ClinicalTrials.gov

Surgeries

1. Gastrostomy tube (G-tube) – for unsafe swallow or poor growth – ensures safe nutrition/hydration and medication delivery.

2. Nissen fundoplication (selected cases) – for severe reflux with aspiration despite maximal therapy – reduces reflux to protect lungs.

3. Soft-tissue tendon lengthening (e.g., adductors, hamstrings, Achilles) – treats fixed contractures that limit care and seating – improves hygiene, comfort, and equipment fit.

4. Hip reconstruction – for progressive hip subluxation/dislocation – restores hip containment and reduces pain.

5. Spinal fusion for scoliosis – when curves progress and affect sitting or breathing – stabilizes spine and improves positioning. (Orthopedic pathways for children with severe motor impairment guide the timing.) NCBI

Prevention tips

1. Early diagnosis and endocrine referral when thyroid profile shows ↑T3/↓T4/↓rT3. NCBI

2. Discuss Triac access with specialists where available; early initiation may be most helpful. The Lancet+1

3. Swallow safety plan to prevent aspiration (positioning, textures, therapy).

4. Vaccinations and respiratory hygiene to prevent infections.

5. Bone health plan (weight-bearing, vitamin D/calcium, sunlight).

6. Hip/scoliosis surveillance to prevent late surgical emergencies.

7. Daily stretching and posture care to prevent contractures and pressure sores.

8. Reflux strategies to limit vomiting and chest infections.

9. Regular dental care to avoid pain, aspiration, and feeding setbacks.

10. Emergency plan (seizures, dehydration, pneumonia signs) to get timely care.

When to see doctors (red-flag list)

• Frequent choking, wet voice, or chest infections (possible aspiration).

• Poor weight gain, dehydration, or vomiting that does not settle.

• Fever with breathing difficulty, fast heart rate, or unusual sleepiness.

• New seizures, unusual movements, or persistent irritability.

• Rapid spine curve, hip pain, or loss of comfortable sitting.

• Any concern about heart rhythm (palpitations, fainting).

• Before starting any supplement that contains iodine or affects thyroid tests. NCBI

What to eat and what to avoid

• Eat: balanced, energy-dense meals; add powders/oils for calories; include protein at each feed; fiber and fluids for constipation; vitamin D and calcium per plan; use thickened liquids or purees if advised; consider G-tube for safety and growth if needed.

• Avoid: excess iodine (non-prescribed seaweed/kelp pills); very thin liquids if swallow unsafe; caffeine/energy drinks that can worsen fast heart rate; fad “thyroid boosters,” unregulated stem-cell or “immune” products. (Diet is supportive; it does not replace medical therapy.) NCBI

Frequently asked questions (FAQs)

1. Is MCT8 deficiency curable?
   Not yet. Care focuses on optimizing development, comfort, and health, and on thyroid-analog therapies that can improve the hormone imbalance. Research and trials are active. The Lancet+1

2. Why is T3 high but the brain acts hypothyroid?
   Because MCT8 is needed to get T3 into brain cells. Without it, the brain is “thyroid-starved” while the blood and body organs can still see high T3. NCBI

3. Do standard thyroid pills (levothyroxine/T3) help?
   Usually no; they may worsen body symptoms without fixing brain entry. Specialist protocols are required. NCBI

4. What is Triac and who should get it?
   Triac (tiratricol) is a T3-like medicine that can get into cells and lower toxic T3 levels. In trials it improved key outcomes; decisions about use and dosing are made by experienced teams. The Lancet

5. Is earlier treatment better?
   Early treatment appears more promising for development, based on trial experience and disease biology. PMC

6. What about DITPA or sobetirome?
   DITPA showed biochemical improvements in small studies; sobetirome/Sob-AM2 have animal data suggesting brain effects. These are not routine therapies yet. PMC+1

7. Are girls affected?
   Most females are asymptomatic carriers, but skewed X-inactivation can cause symptoms in rare cases. Genetic counseling is important. NCBI

8. Which specialists do we need?
   Pediatric endocrinology, neurology, rehabilitation, GI/nutrition, cardiology, orthopedics, pulmonology, and speech/feeding teams—ideally in a coordinated center. Children’s Hospital of Philadelphia

9. How is the diagnosis confirmed?
   By genetic testing showing a pathogenic SLC16A2 variant, in the setting of the typical thyroid hormone pattern. dnatesting.uchicago.edu

10. What does brain MRI show?
    Often delayed myelination, which supports—but does not by itself prove—the diagnosis. NCBI

11. Is gene therapy available?
    Not yet for routine care; it is a research goal under exploration. Bioscientifica

12. Can diet fix the condition?
    No. Diet supports growth and safety but does not replace medical therapy. NCBI

13. Are antithyroid drugs (like methimazole) helpful?
    They lower T3 but risk worsening brain hypothyroidism; they are not standard in MCT8 deficiency unless under specialized protocols. NCBI

14. What is the long-term outlook?
    Motor disability is usually severe, but good supportive care and thyroid-analog therapy can improve comfort, growth, and some clinical measures. PMC+1

15. Where can families read more?
    GeneReviews, NORD, Orphanet, and major children’s hospitals offer reliable summaries and updates.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 12, 2025.